¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dream anxiety attack"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • syncopal attack
    ½Ç½Å¹ßÀÛ
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • sleep attack
    ¼ö¸é¹ßÀÛ
  • anticipatory anxiety
    ¿¹±âºÒ¾È
  • anxiety
    ºÒ¾È
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxiety hysteria
    ºÒ¾ÈÈ÷½ºÅ׸®
  • anxiety neurosis
    ºÒ¾È½Å°æÁõ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • anxiety state
    ºÒ¾È»óÅÂ
  • anxiety syndrome
    ºÒ¾ÈÁõÈıº
  • castration anxiety
    °Å¼¼ºÒ¾È
  • childhood anxiety disorder
    ¼Ò¾ÆºÒ¾ÈÀå¾Ö
  • depressive anxiety
    ¿ì¿ïºÒ¾È
  • disintegration anxiety
    ºØ±«ºÒ¾È
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • anxiety
    ºÒ¾È
  • acute anxiety neurosis
    ±Þ¼ººÒ¾È½Å°æÁõ
  • anticipatory anxiety
    ¿¹±âºÒ¾È
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxiety hysteria
    ºÒ¾ÈÈ÷½ºÅ׸®
  • anxiety neurosis
    ºÒ¾È½Å°æÁõ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • anxiety state
    ºÒ¾È»óÅÂ
  • anxiety syndrome
    ºÒ¾ÈÁõÈıº
  • anxiety tension state
    ºÒ¾È±äÀå»óÅÂ
  • depressive anxiety
    ¿ì¿ïºÒ¾È
  • disintegration anxiety
    ºØ±«ºÒ¾È
  • existential anxiety
    Á¸ÀçºÒ¾È, ½ÇÁ¸ºÒ¾È
  • free floating anxiety
    ¶°µ¹À̺ҾÈ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anxiety syndrome
    ºÒ¾ÈÁõÈıº(¡­ñøý¦ÏØ).
  • anxiety tension state
    ºÒ¾È, ±äÀå»óÅÂ(ÑÌíåßÒ÷¾).
  • anxiety, anticipatory
    ¿¹±âºÒ¾È
  • anxiety, free-floating
    ¸·¿¬ÇÑ ºÒ¾È, ¶°µµ´Â ºÒ¾È
  • anxiety, phobic
    °øÆ÷¼º ºÒ¾È
  • free floating anxiety
    ¶°µ¹ÀÌºÒ¾È (~ÝÕäÌ)
  • generalized anxiety disorder
    ¹üºÒ¾ÈÀå¾Ö(ÛñÝÕäÌî¡äô)(º´)
  • phobic anxiety
    °øÆ÷ºÒ¾È
  • phobic anxiety disorder
    °øÆ÷ºÒ¾ÈÀå¾Ö, ~º´
  • realistic anxiety
    ½ÇÁ¦(-Àû)ºÒ¾È
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • wet dream
    ¸ùÁ¤(ÙÓïñ).
  • asthmatic attack
    õ½Ä¹ßÀÛ(¡­Û¡íÂ).
  • attack
    1. ¹ßÀÛ(Û¡íÂ). 2. °ø°Ý(Íí̪). 3. ¹ß¼º(Û¡á¢).
  • attack of voice
    ¹ß¼º(Û¡á¢).
  • attack rate
    ¹ßº´·ü, ÀÌȯÀ²
  • breath holding attack
    È£ÈíÁßÁö¹ßÀÛ(¡­ñéò­Û¡íÂ).
  • cough attack
    ±âħ¹ßÀÛ(¡­Û¡íÂ).
  • gouty attack
    Åëdz¹ßÀÛ.
  • membrane attack complex
    ¸·°ø°Ýº¹ÇÕü
  • membrane attack complex
    ¸·°ø°Ý º¹ÇÕü(دÍô̪ ÜÜùêô÷)
  • membrane attack complex
    ¼¼Æ÷¸·°ø°Ýº¹ÇÕü
  • panic attack
    °øÈ²¹ßÀÛ
  • paralytic attack
    ¸¶ºñ¼º ¹ßÀÛ(¡­Û¡íÂ).
  • paralytic attack
    ¸¶ºñ¼º ¹ßÀÛ(Ø«Ýöàõ Û¡íÂ)
  • paroxysmal hypercyanostic attack
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TIA Transient Ischemic Attack; Temporary Interference with the blood supply to the brain
ALLHAT Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
BHAT Beta Blocker Heart Attack Trial
HAPPHY Heart Attack Primary Prevention in Hypertension
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ALLHAT and Lipid Lowering Treatment to Prevent Heart Attack Trial
MAC membrane attack complex of complement
ASI Anxiety Sensitivity Index
AS Anxiety sensitivity
BAI Beck Anxiety Inventory
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neurotic anxiety
    ½Å°æÁõÀû ºÒ¾È
  • organic anxiety syndrome
    ±âÁúÀû ºÒ¾È ÁõÈıº
    ¼¶¸ÁÀÇ °æ¿ì¸¦ Á¦¿ÜÇÑ ´Ù¸¥ ¾î¶² Ư¼öÇÑ ±âÁúÀû ÀÎÀÚ·Î ÀÎÇØ ¹Ýº¹Çؼ­ »ý±â´Â ½ÉÇÑ °øÈ² ¹ßÀÛ ¶Ç´Â ¹üºÒ¾È µîÀÌ Æ¯Â¡ÀÎ ±âÁúÀû Á¤½Å ¡ÈÄ, ±× ¿øÀÎÀ¸·Î °©»ó¼± ±â´É Ç×Áø, °©»ó¼± ±â´É ÀúÇÏ, Å©·Ò ģȭ¼º ¼¼Æ÷Á¾, °øº¹½Ã ÀúÇ÷´ç, ºÎ½Å ÇÇÁú ±â´É Ç×Áø µîÀÇ ³»ºÐºñ Àå¾Ö³ª ¶Ç´Â Á¤½Å Ȱ¼º ¾à¹°ÀÇ »ç¿ë µîÀÌ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
transient ischaemic attack A transient ischaemic attack is a temporary paralysis, numbness, speech difficulty or other neurologic symptoms that start suddenly and recovers within 24 hours (typically resolve over several hours).
See: neurologic symptoms, stroke.
Acronym: TIA
(26 Mar 1998)
transient ischemic attack A sudden focal loss of neurological function with complete recovery usually within 24 hours; caused by a brief period of inadequate perfusion in a portion of the territory of the carotid or vertebral basilar arteries.
(05 Mar 2000)
uncinate attack A form of psychomotor epilepsy or complex partial seizure initiated by a dreamy state and hallucinations of smell and taste, usually the result of a medial temporal lesion.
Synonym: uncinate attack.
(05 Mar 2000)
anti-anxiety agents Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here.
Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants.
(12 Dec 1998)
anxiety <psychology> The unpleasant emotional state consisting of psychophysiological responses to anticipation of unreal or imagined danger, ostensibly resulting from unrecognised intrapsychic conflict.
Physiological concomitants include increased heart rate, altered respiration rate, sweating, trembling, weakness and fatigue, psychological concomitants include feelings of impending danger, powerlessness, apprehension and tension.
(18 Nov 1997)
anxiety, castration Anxiety due to fantasied injuries to or loss of the genitals.
(12 Dec 1998)
anxiety disorders Disorders in which anxiety (persistent feelings of apprehension, tension, or uneasiness) is the predominant disturbance.
(12 Dec 1998)
anxiety hysteria Hysteria characterised by manifest anxiety.
(05 Mar 2000)
anxiety neurosis Chronic abnormal distress and worry to the point of panic followed by a tendency to avoid or run from the feared situation, associated with overaction of the sympathetic nervous system.
(05 Mar 2000)
anxiety reaction A sudden bout of anxiety that is often accompanied by the features of hyperventilation (tingling around mouth and in fingertips, rapid breathing, faintness or fainting).
(27 Sep 1997)
anxiety, separation Anxiety experienced by an individual upon separation from a person or object of particular significance to him.
(12 Dec 1998)
anxiety syndrome <syndrome> The constellation of autonomic nervous system signs and symptoms accompanying the apprehension of danger and dread.
See: anxiety.
(05 Mar 2000)
anxiety tension state A milder form of an anxiety disorder.
See: anxiety disorders.
(05 Mar 2000)
manifest anxiety scale True-false questionnaire made up of items believed to indicate anxiety, in which the subject answers verbally the statement that describes him.
(12 Dec 1998)
generalised anxiety disorder Chronic, repeated episodes of anxiety reactions; a psychological disorder in which anxiety or morbid fear and dread accompanied by autonomic changes are prominent features.
See: anxiety.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dream reader
    ÇØ¸ù°¡
  • pipe dream
    (¾ÆÆí Èí¿¬ÀÚ°¡ ÇÏ´Â µûÀ§)Å« °ø»ó
  • pipe dream
    Å« °ø»ó;¾ÆÆí Èí¿¬ÀÚ°¡ ÇÏ´Â µûÀ§ÀÇ
  • wet dream
    ¸ùÁ¤
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á